Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Silencing tissue inhibitors of metalloproteinases (TIMPs) with short interfering RNA reveals a role for TIMP-1 in hepatic stellate cell proliferation.

Fowell AJ, Collins JE, Duncombe DR, Pickering JA, Rosenberg WM, Benyon RC.

Biochem Biophys Res Commun. 2011 Apr 8;407(2):277-82. doi: 10.1016/j.bbrc.2011.02.009. Epub 2011 Feb 15.

PMID:
21300026
2.
3.

Adiponectin reduces hepatic stellate cell migration by promoting tissue inhibitor of metalloproteinase-1 (TIMP-1) secretion.

Ramezani-Moghadam M, Wang J, Ho V, Iseli TJ, Alzahrani B, Xu A, Van der Poorten D, Qiao L, George J, Hebbard L.

J Biol Chem. 2015 Feb 27;290(9):5533-42. doi: 10.1074/jbc.M114.598011. Epub 2015 Jan 9.

4.

Inhibition of connective tissue growth factor suppresses hepatic stellate cell activation in vitro and prevents liver fibrosis in vivo.

Hao C, Xie Y, Peng M, Ma L, Zhou Y, Zhang Y, Kang W, Wang J, Bai X, Wang P, Jia Z.

Clin Exp Med. 2014 May;14(2):141-50. doi: 10.1007/s10238-013-0229-6. Epub 2013 Mar 2.

PMID:
23456538
5.
6.

Down-regulation of tTG expression by RNAi inhibits HSC proliferation and attenuates liver fibrosis.

Zhao G, Zhang ZQ, Zhang B, Luo M, Sun YW, Wu ZY.

Int J Clin Exp Pathol. 2011 Jun 20;4(5):513-20. Epub 2011 Jun 12.

7.

[Effect of shRNA-mediated silencing of CTGF and TIMP-1 on mRNA expression of CTGF, TIMP-1, and PC I and secretion of extracellular matrix in rat hepatic stellate cells].

Jiang YF, Sun HL, Zhang JJ, Huang F, Liu JQ.

Zhonghua Gan Zang Bing Za Zhi. 2012 Aug;20(8):576-80. doi: 10.3760/cma.j.issn.1007-3418.2012.08.007. Chinese.

PMID:
23207149
8.

Tissue inhibitors of metalloproteinases, hepatic stellate cells and liver fibrosis.

Arthur MJ, Mann DA, Iredale JP.

J Gastroenterol Hepatol. 1998 Sep;13 Suppl:S33-8. Review.

PMID:
9792032
9.

Liver fibrosis, the hepatic stellate cell and tissue inhibitors of metalloproteinases.

McCrudden R, Iredale JP.

Histol Histopathol. 2000 Oct;15(4):1159-68. Review.

PMID:
11005241
10.

MeCP2 silencing of LncRNA H19 controls hepatic stellate cell proliferation by targeting IGF1R.

Yang JJ, Liu LP, Tao H, Hu W, Shi P, Deng ZY, Li J.

Toxicology. 2016 Jun 1;359-360:39-46. doi: 10.1016/j.tox.2016.06.016. Epub 2016 Jun 24.

PMID:
27350269
11.
12.

Antifibrotic effects of a recombinant adeno-associated virus carrying small interfering RNA targeting TIMP-1 in rat liver fibrosis.

Cong M, Liu T, Wang P, Fan X, Yang A, Bai Y, Peng Z, Wu P, Tong X, Chen J, Li H, Cong R, Tang S, Wang B, Jia J, You H.

Am J Pathol. 2013 May;182(5):1607-16. doi: 10.1016/j.ajpath.2013.01.036. Epub 2013 Mar 7.

PMID:
23474083
13.

Inhibition of high-mobility group box 1 expression by siRNA in rat hepatic stellate cells.

Ge WS, Wu JX, Fan JG, Wang YJ, Chen YW.

World J Gastroenterol. 2011 Sep 28;17(36):4090-8. doi: 10.3748/wjg.v17.i36.4090.

14.

Activated hepatic stellate cells are dependent on self-collagen, cleaved by membrane type 1 matrix metalloproteinase for their growth.

Birukawa NK, Murase K, Sato Y, Kosaka A, Yoneda A, Nishita H, Fujita R, Nishimura M, Ninomiya T, Kajiwara K, Miyazaki M, Nakashima Y, Ota S, Murakami Y, Tanaka Y, Minomi K, Tamura Y, Niitsu Y.

J Biol Chem. 2014 Jul 18;289(29):20209-21. doi: 10.1074/jbc.M113.544494. Epub 2014 May 27.

15.

Tissue inhibitor of metalloproteinase-1 and -2 RNA expression in rat and human liver fibrosis.

Herbst H, Wege T, Milani S, Pellegrini G, Orzechowski HD, Bechstein WO, Neuhaus P, Gressner AM, Schuppan D.

Am J Pathol. 1997 May;150(5):1647-59.

16.

Tissue inhibitors of metalloproteinases, hepatic stellate cells and liver fibrosis.

Arthur MJ, Mann DA, Iredale JP.

J Gastroenterol Hepatol. 1998 Sep;13(S1):S33-S38. doi: 10.1111/jgh.1998.13.s1.33.

PMID:
28976699
17.

Mechanisms of spontaneous resolution of rat liver fibrosis. Hepatic stellate cell apoptosis and reduced hepatic expression of metalloproteinase inhibitors.

Iredale JP, Benyon RC, Pickering J, McCullen M, Northrop M, Pawley S, Hovell C, Arthur MJ.

J Clin Invest. 1998 Aug 1;102(3):538-49.

18.

Tissue inhibitors of metalloproteinases: role in liver fibrosis and alcoholic liver disease.

Arthur MJ, Iredale JP, Mann DA.

Alcohol Clin Exp Res. 1999 May;23(5):940-3. Review.

PMID:
10371419
19.

Combined taurine, epigallocatechin gallate and genistein therapy reduces HSC-T6 cell proliferation and modulates the expression of fibrogenic factors.

Li Y, Luo Y, Zhang X, Lin X, He M, Liao M.

Int J Mol Sci. 2013 Oct 14;14(10):20543-54. doi: 10.3390/ijms141020543.

20.

[Effects of Shaoqiduogan on MMP-13, TIMP-1 expression in liver and hepatic stellate cells of hepatic fibrosis rats].

Sun W, Gui S, Wu L, Wang H, Wei W.

Zhongguo Zhong Yao Za Zhi. 2010 Jun;35(11):1447-51. Chinese.

PMID:
20822018

Supplemental Content

Support Center